Shinyu Izumi

Dr. Shinyu Izumi

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in Respiratory Investigation
Verified
Journal Article
Closed access
SHShu Hisata
Shu Hisata
MBMasashi Bando
Masashi Bando
SHSakae Homma
Sakae Homma
KKKensuke Kataoka
Kensuke Kataoka
TOTakashi Ogura
Takashi Ogura
NINaohiko Inase
Naohiko Inase

23 March 2022 in Respirology Case Reports
Verified
Journal Article
Open access
CSClara So
Clara So
SIShinyu Izumi
Shinyu Izumi
AIAkane Ishida
Akane Ishida
RHRyo Hirakawa
Ryo Hirakawa
YKYusaku Kusaba
Yusaku Kusaba
MHMasayuki Hojo
Masayuki Hojo
The Pfizer‐BioNTech mRNA vaccine (BNT162b2) is an effective and well‐tolerated coronavirus disease 2019 (COVID‐19) vaccine. However, rare adverse events have been reported. We report two cases of COVID‐19 mRNA vaccine‐related interstitial lung disease (ILD). A 67‐year‐old man and a 70‐year‐old man with underlying ILD presented to our hospital with a few days of fever and respiratory symptoms after receiving the BNT162b2 vaccine. Drug‐related pneumonitis due to the COVID‐19 mRNA vaccine was diagnosed. One case was diagnosed with lymphocytic alveolitis by bronchoalveolar lavage fluid and transbronchial lung cryobiopsy. Both patients were successfully treated with corticosteroids, and they attended outpatient clinics thereafter. Although the safety and efficacy of COVID‐19 vaccines have been established, further studies are needed to estimate long‐term data and reports of rare adverse reactions. We present the clinical course of two cases, review previously published case reports on COVID‐19 mRNA vaccine‐related ILD and discuss the relevant findings.

1 December 2015 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
TMToshie Manabe
Toshie Manabe
KYKazue Yamaoka
Kazue Yamaoka
TTToshiro Tango
Toshiro Tango
NBNguyen Gia Binh
Nguyen Gia Binh
DCDao Xuan Co
Dao Xuan Co
KKKoichiro Kudo
Koichiro Kudo
Human cases of highly pathogenic avian influenza A (H5N1) virus infection continue to occur in Southeast Asia. The objective of this study was to identify when and where human H5N1 cases have occurred in Vietnam and how the situation has changed from the beginning of the H5N1 outbreaks in 2003 through 2014, to assist with implementing methods of targeted disease management. We assessed the disease clustering and seasonal variation of human H5N1 cases in Vietnam to evaluate the geographical and monthly timing trends. The clustering of H5N1 cases and associated mortality were examined over three time periods: the outbreak period (2003–2005), the post-outbreak (2006–2009), and the recent period (2010–2014) using the flexibly shaped space-time scan statistic. The most likely cases to co-cluster and the elevated risks for incidence and mortality were assessed via calculation of the relative risk (RR). The H5N1 case seasonal variation was analysed as the cyclic trend in incidence data using Roger’s statistical test. Between 2003 and 2005, H5N1 cases (RR: 2.15, p = 0.001) and mortality (RR: 2.49, p = 0.021) were significantly clustered in northern Vietnam. After 2010, H5N1 cases tended to occur on the border with Cambodia in the south, while H5N1 mortality clustered significantly in the Mekong delta area (RR: 6.62, p = 0.002). A significant seasonal variation was observed (p < 0.001), with a higher incidence of morbidity in December through April. These findings indicate that clinical preparedness for H5N1 in Vietnam needs to be strengthened in southern Vietnam in December–April.

1 January 2017 in Respiratory Investigation
Verified
Journal Article
Closed access
ASAki Sakurai
Aki Sakurai
HYHidekatsu Yanai
Hidekatsu Yanai
TITsuyoshi Ishida
Tsuyoshi Ishida
HKHiromi Kuwata
Hiromi Kuwata
Katsuhiko KameiKatsuhiko Kamei
Katsuhiko Kamei
SIShinyu Izumi
Shinyu Izumi

10 February 2022 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
MMMomoko Morishita
Momoko Morishita
MSManabu Suzuki
Manabu Suzuki
AMAkihiro Matsunaga
Akihiro Matsunaga
KIKeishi Ishizhima
Keishi Ishizhima
TYTsukasa Yamamoto
Tsukasa Yamamoto
HSHaruhito Sugiyama
Haruhito Sugiyama

11 July 2023 in Respiratory Investigation
Verified
Journal Article
Closed access
MOMiwako Omori
Miwako Omori
YMYuji Minegishi
Yuji Minegishi
HUHironori Uruga
Hironori Uruga
AFAya Fukuizumi
Aya Fukuizumi
KIKazutoshi Isobe
Kazutoshi Isobe
KKKazuma Kishi
Kazuma Kishi